Dr. Iagaru is a Professor of Radiology – Nuclear Medicine and the Chief of the Division of Nuclear Medicine and Molecular Imaging at Stanford University Medical Center. He
completed medical school at Carol Davila University of Medicine, Bucharest, Romania, and an internship at Drexel University College of Medicine, Graduate Hospital, in the Department of Medicine in Philadelphia. He began his residency at the University of Southern California (USC) Keck School of Medicine, Los Angeles, in the Division of Nuclear Medicine. Dr. Iagaru finished his residency and completed a PET/CT fellowship at Stanford University’s School of Medicine in the Division of Nuclear Medicine. His research interests include PET/MRI and PET/CT for early cancer detection; clinical translation of novel PET radiopharmaceuticals; peptide-based diagnostic imaging and therapy; targeted radionuclide therapy.
Since joining the faculty at Stanford in 2007, Dr. Iagaru has received several awards including the Society of Nuclear Medicine (SNM) 2009 Image of the Year Award;
AuntMinnie 2016 Best Radiology Image, American College of Nuclear Medicine (ACNM) Mid-Winter Conference 2010 Best Essay Award; 2009, 2014 and 2015 Western Regional SNM Scientist Award; 2011 SNM Nuclear Oncology Council Young Investigator Award; the 2020 Sanjiv Sam Gambhir Distinguished Scientist Award, Western Regional SNM and the 2022 Sanjiv Sam Gambhir Trailblazer Award, SNMMI.
Dr. Iagaru published more than 210 papers in peer-reviewed journals, as well as 9 book chapters and 1 book.
Learning objectives:
1) Identify complementary roles of PSMA and GRPR PET for evaluation of intermediate- and high-risk prostate cancer prior to prostatectomy.
2) Identify complementary roles of PSMA and GRPR PET for evaluation of BCR prostate cancer.
3) Identify exploratory roles of PSMA and GRPR PET for biopsy guidance of suspected prostate cancer and for local therapy guidance/evaluation of response.
IASNM Radiant Flashpoints Educational Web- Series
In honor of Dr. Sam Gambhir and in collaboration with MISI (Molecular Imaging Society – India)
Leave a Reply